Radicle Revive Randomized Double-Blind Menopausal Health Study
Summary
Radicle Revive™ clinical study NCT07548307 has been registered on ClinicalTrials.gov as a randomized, double-blind, placebo-controlled trial evaluating the impact of health and wellness products on menopausal-related health issues. The study's condition focus includes Cognitive Function, with interventions comparing Revive Active Product 1 against a placebo control. The trial is listed with an estimated completion date of April 23, 2026.
“Radicle Revive™: A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on menopausal-related health issues associated health outcomes.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
This registry entry announces the registration of Radicle Revive™ clinical study NCT07548307 on ClinicalTrials.gov, conducted as a randomized, double-blind, placebo-controlled trial. The study will assess health and wellness products against placebo for menopausal-related health outcomes, specifically targeting Cognitive Function as a condition of interest. The trial involves Revive Active Product 1 compared against a Revive Product Placebo Control.
For companies developing health and wellness products targeting menopausal or cognitive health, this registry entry serves as notice of an upcoming clinical trial that may establish product efficacy benchmarks. Healthcare providers and clinical investigators may use this listing to identify potential study participation opportunities or competitive landscape awareness for women's health interventions.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Radicle Revive™: A Study Assessing the Impact of Health and Wellness Products on Menopausal-Related Health Issues Associated Health Outcomes and Related Health Outcomes
N/A NCT07548307 Kind: NA Apr 23, 2026
Abstract
Radicle Revive™: A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on menopausal-related health issues associated health outcomes.
Conditions: Cognitive Function
Interventions: Revive Product Placebo Control, Revive Active Product 1
Parties
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.